I'm glad that you pointed this out because like Cherie stated in an earlier post, when we mention this kind of news in the thread, some people become quite upset.

Biogen's marketing/sales department aren't dummies. They know very well that mention of the word PML with Tysabri sends their stock tumbling. They also know that the longer Tysabri is on the market the greater the number of PML cases that are going to appear. By not publicly reporting the PML cases as of the end of this month they are protecting the revenue generation of the drug...and THAT is what it is all about for Biogen and always will be.

And they are going to spread the info by "word of mouth" to the docs!! Biogen has one of the worst reputations going in the medical field when it comes to trustworthy information. And that was told to me by a neuro who was inovled in the original Tysabri trials!!

Harry